Pages that link to "Q35039205"

The following pages link to Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. (Q35039205):

Displaying 25 items.

• Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses (Q24613799) (← links)
• Bayesian Analysis of a Lipid-Based Physiologically Based Toxicokinetic Model for a Mixture of PCBs in Rats (Q27496000) (← links)
• Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents (Q28742140) (← links)
• Persistent organic pollutants in adipose tissue should be considered in obesity research (Q30240226) (← links)
• An assessment of dioxin exposure across gestation and lactation using a PBPK model and new data from Seveso (Q31068651) (← links)
• Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. (Q33837788) (← links)
• Childhood obesity and environmental chemicals (Q34789938) (← links)
• Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding (Q34972720) (← links)
• Metabolic outcome of female mice exposed to a mixture of low-dose pollutants in a diet-induced obesity model. (Q35535741) (← links)
• Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. (Q35920258) (← links)
• Isomer pattern and elimination of dioxins in workers exposed at a municipal waste incineration plant (Q36113298) (← links)
• Elimination rates of dioxin congeners in former chlorophenol workers from Midland, Michigan (Q36556073) (← links)
• Toxicological function of adipose tissue: focus on persistent organic pollutants. (Q36602294) (← links)
• Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. (Q37086425) (← links)
• Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice (Q37253515) (← links)
• Dietary fat alters body composition, mammary development, and cytochrome p450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors (Q37331186) (← links)
• In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment (Q42871357) (← links)
• Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human (Q44019028) (← links)
• Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment (Q46186790) (← links)
• Scientific statement on the health-based guidance values for dioxins and dioxin-like PCBs (Q47157010) (← links)
• Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells (Q49476204) (← links)
• Physiologically-based modeling of the pharmacokinetics of "catch-and-release" anti-carcinoembryonic antigen monoclonal antibodies in colorectal cancer xenograft mouse models (Q57471664) (← links)
• Risk for animal and human health related to the presence of dioxins and dioxin‐like PCBs in feed and food (Q62086878) (← links)
• The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling (Q88215222) (← links)
• Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (Q93141296) (← links)